Ossimaxx (Oxygen)

Ossimaxx is a medical gas used in clinical settings that require supplemental oxygen therapy.

• Acute hypoxemia: Improves arterial oxygen saturation during emergency and critical care.
• Peri‑operative care: Provides controlled oxygen delivery during anesthesia and postoperative recovery.
• Chronic respiratory disorders: Supports patients with COPD, interstitial lung disease or other conditions causing long‑term oxygen dependence.
• High‑altitude exposure: Assists individuals experiencing altitude‑related hypoxia.
• Diagnostic imaging: Enhances image quality in certain radiologic procedures requiring patient oxygenation.

• Ossimaxx delivers molecular oxygen directly to the alveolar space, increasing the partial pressure of oxygen in the lungs. This creates a diffusion gradient that facilitates the transfer of oxygen into the bloodstream, raising arterial oxygen content and supporting cellular metabolism across tissues.

Ossimaxx may cause a range of adverse reactions, most of which are related to the delivery system or excessive oxygen exposure.

Common Side Effects

• Dry mouth or throat irritation.
• Nasal mucosal dryness.
• Mild headache.
• Cough or mild bronchospasm.
• Discomfort from mask or cannula.

Serious or Rare Side Effects

• Oxygen toxicity leading to pulmonary inflammation.
• Retinopathy of prematurity in neonates.
• Seizures in patients with high oxygen concentrations.
• Barotrauma from high‑pressure delivery systems.
• Hypercapnia in patients with compromised ventilation.
• Allergic reaction to delivery device materials.

When using Ossimilxx, clinicians should observe standard safety measures and patient‑specific considerations.

• Patient assessment: Verify indication and baseline oxygen saturation before initiation.
• Flow rate selection: Adjust to maintain target SpO2 while avoiding hyperoxia.
• Monitoring: Continuously monitor respiratory status and arterial blood gases.
• Contraindications: Avoid in patients with known sensitivity to device components.
• Fire safety: Keep away from open flames and sources of ignition.
• Store at ambient temperature: Keep container in original packaging, protect from direct sunlight and moisture.

Ossimaxx can interact with other therapies that affect respiratory function or oxygen utilization.

Major Interactions (Avoid)

• High‑flow oxygen with nitrous oxide anesthesia.
• Concurrent use of certain bronchodilators that may cause excessive airway pressure.

Moderate Interactions (Monitor Closely)

• Sedatives and opioids that depress respiratory drive.
• Positive pressure ventilation settings.
• Inhaled nitric oxide therapy.
• Hyperbaric oxygen therapy.
• Supplemental carbon dioxide removal systems.